Corcept Therapeutics Inc
F:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
Relmada Therapeutics Inc
F:4E2
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 91.74 EUR with a low forecast of 59.3 EUR and a high forecast of 154.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
91.74
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 91.74 EUR with a low forecast of 59.3 EUR and a high forecast of 154.13 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 17%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
58%
The compound annual growth rate for Operating Income over the next 8 years is 58%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
36%
The compound annual growth rate for Net Income over the next 8 years is 36%.
